Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)

Heredia, DavidBarrón-Barrón, FelicianoCardona, Andrés FelipeCampos, Saul T.Rodríguez-Cid, Jerónimo RafaelMartínez-Barrera, Luis ManuelAlatorre, JorgeSalinas, Miguel ÁngelLara-Mejía, LuisFlores-Estrada, DianaArrieta, Oscar2021-04-142021-04-142021-011744-8301https://hdl.handle.net/20.500.12495/5776application/pdfengBrigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)Artículo de revistaAnaplastic lymphoma kinaseBrigatinibCeritinibCrizotinibEarly accessLung cancerNon-small cell lung cancerReal-world evidencehttps://doi.org/10.2217/fon-2020-0747instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coBrigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)Acceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto